Jane Street’s Calithera Biosciences, Inc CALA Stock Holding History

Jane Street’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,820	Closed	-$277K	–	9846
2020 Q4	$277K	Buy	+2,820	New	+$247K	﹤0.01%	6534

Other funds holding CALA

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Jane Street's CALA Position: Q1 2022 in Review

Jane Street sold out of Calithera Biosciences, Inc (CALA) in Q1 2022, closing a stake of 5,001 shares — an estimated $67K sold.

Jane Street first reported a position in CALA in Q1 2017 and held it in 8 quarters. The position peaked at $390K in Q4 2019. 54 funds tracked by Wall St. Rank hold CALA as of Q1 2022.

Jane Street reported no remaining Calithera Biosciences, Inc position as of Q1 2022 after selling out during the quarter.
Jane Street sold 5,001 Calithera Biosciences, Inc shares in Q1 2022, an estimated $67K.
Jane Street first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 8 quarters.
Jane Street's Calithera Biosciences, Inc position peaked at $390K in Q4 2019.
54 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.